Thrombosis in Haematological Disorders: Tailored Management Approaches

Summary of presentations from the Alexion-supported satellite symposium held at the 20th Congress of the European Hematology Association (EHA) on 11th-14th June 2015, Vienna, Austria

Chairperson: Anna Falanga1
Speakers: T. Sakari Jokiranta,2 Anita Hill3

1. Hospital Papa Giovanni XXIII, Bergamo, Italy
2. University of Helsinki, Helsinki, Finland
3. Leeds Teaching Hospitals NHS Trust, Leeds, UK

Disclosure: Anna Falanga has received speaker fees, consultancy, and research support from Alexion Pharmaceuticals. T. Sakari Jokiranta has received honoraria for lectures from Pfizer, Merck Sharp & Dohme, Alexion Pharmaceuticals, Scopeful, Abbvie, Medac, and Roche, received consultation fees from Pfizer, Merck Sharp & Dohme, and Alexion Pharmaceuticals, and is a shareholder for Scopeful. Anita Hill has received honoraria from Alexion Pharmaceuticals and served on advisory boards.
Acknowledgements: Writing assistance was provided by Dr Saroshi Amirthalingam, apothecom scopemedical Ltd.
Support: The publication of this article was funded by Alexion. The views and opinions expressed are those of the authors and not necessarily of Alexion.
Citation: EMJ Hema. 2015;3[1]:38-46.

Meeting Summary

The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases. Adjunct Prof Sakari Jokiranta gave an overview of the complement system and the interplay between the complement and coagulation systems. Dysregulation of complement and resulting disease states were also discussed. The session was concluded with a presentation from Dr Anita Hill on the management of thrombosis in paroxysmal nocturnal haemoglobinuria (PNH).

Download (PDF, 954KB)

Comments are closed.